This company has been marked as potentially delisted and may not be actively trading. Aesther Healthcare Acquisition (AEHA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock AEHA vs. SBTX, MBX, NLTX, CYBN, BIOA, VIRI, AVTE, WHWK, OSTX, and ATNMShould you be buying Aesther Healthcare Acquisition stock or one of its competitors? The main competitors of Aesther Healthcare Acquisition include Silverback Therapeutics (SBTX), MBX Biosciences (MBX), Neoleukin Therapeutics (NLTX), Cybin (CYBN), BioAge Labs (BIOA), Virios Therapeutics (VIRI), Aerovate Therapeutics (AVTE), Whitehawk Therapeutics (WHWK), OS Therapies (OSTX), and Actinium Pharmaceuticals (ATNM). Aesther Healthcare Acquisition vs. Its Competitors Silverback Therapeutics MBX Biosciences Neoleukin Therapeutics Cybin BioAge Labs Virios Therapeutics Aerovate Therapeutics Whitehawk Therapeutics OS Therapies Actinium Pharmaceuticals Aesther Healthcare Acquisition (NASDAQ:AEHA) and Silverback Therapeutics (NASDAQ:SBTX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, valuation, earnings, institutional ownership and dividends. Does the media prefer AEHA or SBTX? In the previous week, Silverback Therapeutics had 1 more articles in the media than Aesther Healthcare Acquisition. MarketBeat recorded 1 mentions for Silverback Therapeutics and 0 mentions for Aesther Healthcare Acquisition. Silverback Therapeutics' average media sentiment score of 1.16 beat Aesther Healthcare Acquisition's score of 0.00 indicating that Silverback Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Aesther Healthcare Acquisition Neutral Silverback Therapeutics Positive Is AEHA or SBTX more profitable? Aesther Healthcare Acquisition's return on equity of 0.00% beat Silverback Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Aesther Healthcare AcquisitionN/A N/A N/A Silverback Therapeutics N/A -29.62%-28.20% Do institutionals & insiders have more ownership in AEHA or SBTX? 78.6% of Aesther Healthcare Acquisition shares are held by institutional investors. Comparatively, 74.9% of Silverback Therapeutics shares are held by institutional investors. 19.8% of Aesther Healthcare Acquisition shares are held by insiders. Comparatively, 34.4% of Silverback Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility & risk, AEHA or SBTX? Aesther Healthcare Acquisition has a beta of 0.04, meaning that its share price is 96% less volatile than the S&P 500. Comparatively, Silverback Therapeutics has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. Which has higher valuation and earnings, AEHA or SBTX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAesther Healthcare AcquisitionN/AN/A-$560KN/AN/ASilverback TherapeuticsN/AN/A-$89.48M-$2.42-5.70 SummaryAesther Healthcare Acquisition and Silverback Therapeutics tied by winning 4 of the 8 factors compared between the two stocks. Get Aesther Healthcare Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for AEHA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AEHA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AEHA vs. The Competition Export to ExcelMetricAesther Healthcare AcquisitionPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$49K$817.04M$5.75B$9.60BDividend YieldN/A4.84%4.54%4.09%P/E RatioN/A1.1530.4025.01Price / SalesN/A25.62415.24176.62Price / CashN/A19.5637.3459.16Price / Book-0.036.538.956.28Net Income-$560K-$4.93M$3.26B$265.47M Aesther Healthcare Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AEHAAesther Healthcare AcquisitionN/A$0.00+5.7%N/A-100.0%$49KN/A0.002,021Gap DownSBTXSilverback TherapeuticsN/A$14.47-8.5%N/A-1.5%$521.76MN/A-5.9883News CoveragePositive NewsHigh Trading VolumeMBXMBX Biosciences2.5623 of 5 stars$14.72+11.4%$37.75+156.5%N/A$494.50MN/A-3.2436News CoverageNLTXNeoleukin TherapeuticsN/A$20.20-4.3%N/A-41.6%$189.84MN/A-6.5090High Trading VolumeCYBNCybin2.4419 of 5 stars$7.06-1.5%$85.00+1,104.0%N/A$166.55MN/A-1.6150Trending NewsAnalyst RevisionBIOABioAge LabsN/A$4.55+2.0%N/AN/A$159.89MN/A0.00N/AHigh Trading VolumeVIRIVirios TherapeuticsN/A$4.92+2.5%$5.00+1.6%+2,617.9%$94.75MN/A-18.225Gap DownAVTEAerovate TherapeuticsN/A$6.77-7.6%N/A-88.4%$77.68MN/A-2.2620High Trading VolumeWHWKWhitehawk TherapeuticsN/A$1.60-1.2%N/AN/A$76.35M$25.98M-26.6740High Trading VolumeOSTXOS Therapies2.2364 of 5 stars$2.06-4.2%$18.00+773.8%-45.8%$67.99MN/A-2.40N/ANews CoverageAnalyst ForecastATNMActinium Pharmaceuticals2.9434 of 5 stars$1.69+2.4%$4.50+166.3%-21.4%$52.72MN/A-1.2230Positive NewsShort Interest ↓ Related Companies and Tools Related Companies SBTX Alternatives MBX Alternatives NLTX Alternatives CYBN Alternatives BIOA Alternatives VIRI Alternatives AVTE Alternatives WHWK Alternatives OSTX Alternatives ATNM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AEHA) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aesther Healthcare Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aesther Healthcare Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access